Evidence map›Paper›PMID 29211798›Full record

ArticlePLoS pathogens2017

LipL21 lipoprotein binding to peptidoglycan enables Leptospira interrogans to escape NOD1 and NOD2 recognition.

Gwenn Ratet, Ignacio Santecchia, Martine Fanton d'Andon, Frédérique Vernel-Pauillac, Richard Wheeler, Pascal Lenormand, Frédéric Fischer, Pierre Lechat, David A Haake, Mathieu Picardeau and 2 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Evaluation ofFrontiers in microbiology · 2023
    Article
  9. Review
  10. Article
  11. Host and Species-Specificities of Pattern Recognition Receptors Upon Infection WithFrontiers in cellular and infection microbiology · 2022
    Review
  12. Screening of Surface-Exposed Lipoproteins ofFrontiers in microbiology · 2022
    Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Gwenn RatetInstitut Pasteur, Unité Biologie et Génétique de la Paroi Bactérienne, Paris, France.ORCID 0000-0003-0595-8034
Ignacio SantecchiaInstitut Pasteur, Unité Biologie et Génétique de la Paroi Bactérienne, Paris, France.
Martine Fanton d'AndonInstitut Pasteur, Unité Biologie et Génétique de la Paroi Bactérienne, Paris, France.ORCID 0000-0002-1587-5147
Frédérique Vernel-PauillacInstitut Pasteur, Unité Biologie et Génétique de la Paroi Bactérienne, Paris, France.
Richard WheelerInstitut Pasteur, Unité Biologie et Génétique de la Paroi Bactérienne, Paris, France.ORCID 0000-0002-9249-2377
Pascal LenormandInstitut Pasteur, Génopole (Protéopole), Paris, France.
Frédéric FischerInstitut Pasteur, Unité de pathogenèse de Helicobacter, Paris, France.ORCID 0000-0003-1549-8692
Pierre LechatInstitut Pasteur, Hub Bioinformatique et Biostatistique, C3BI, USR 3756 IP CNRS, Paris, France.
David A HaakeVeterans Affairs Greater Los Angeles Healthcare System, Los Angeles, California, United States of America.ORCID 0000-0002-8468-6526
Mathieu PicardeauInstitut Pasteur, Unité Biologie des Spirochètes, Paris, France.
Ivo G BonecaInstitut Pasteur, Unité Biologie et Génétique de la Paroi Bactérienne, Paris, France.ORCID 0000-0001-8122-509X
Catherine WertsInstitut Pasteur, Unité Biologie et Génétique de la Paroi Bactérienne, Paris, France.ORCID 0000-0003-3079-5476
Inserm · FRInstitut Pasteur · FRCentre National de la Recherche Scientifique · FRUniversity of California, Los Angeles · US

Funding

Outer Membrane Proteins of Pathogenic Leptospira SpeciesR01AI034431 · NIAID · BRENTWOOD BIOMEDICAL RESEARCH INSTITUTE · PI GOMES-SOLECKI, MARIA, HAAKE, DAVID A · 2003 to 2015
$4.1M
Virulence Proteins of Pathogenic Leptospira SpeciesR21AI128560 · NIAID · BRENTWOOD BIOMEDICAL RESEARCH INSTITUTE · PI HAAKE, DAVID A · 2017 to 2018
$357k
NIAID NIH HHS R01 AI034431NIAID NIH HHS R21 AI128560
6 · The paper itself

Abstract

Leptospirosis is a widespread zoonosis, potentially severe in humans, caused by spirochetal bacteria, Leptospira interrogans (L. interrogans). Host defense mechanisms involved in leptospirosis are poorly understood. Recognition of lipopolysaccharide (LPS) and lipoproteins by Toll-Like Receptors (TLR)4 and TLR2 is crucial for clearance of leptospires in mice, yet the role of Nucleotide Oligomerization Domain (NOD)-like receptors (NOD)1 and NOD2, recognizing peptidoglycan (PG) fragments has not previously been examined. Here, we show that pathogenic leptospires escape from NOD1 and NOD2 recognition both in vitro and in vivo, in mice. We found that leptospiral PG is resistant to digestion by certain hydrolases and that a conserved outer membrane lipoprotein of unknown function, LipL21, specific for pathogenic leptospires, is tightly bound to the PG. Leptospiral PG prepared from a mutant not expressing LipL21 (lipl21-) was more readily digested than the parental or complemented strains. Muropeptides released from the PG of the lipl21- mutant, or prepared using a procedure to eliminate the LipL21 protein from the PG of the parental strain, were recognized in vitro by the human NOD1 (hNOD1) and NOD2 (hNOD2) receptors, suggesting that LipL21 protects PG from degradation into muropeptides. LipL21 expressed in E. coli also resulted in impaired PG digestion and NOD signaling. We found that murine NOD1 (mNOD1) did not recognize PG of L. interrogans. This result was confirmed by mass spectrometry showing that leptospiral PG was primarily composed of MurTriDAP, the natural agonist of hNOD1, and contained only trace amounts of the tetra muropeptide, the mNOD1 agonist. Finally, in transgenic mice expressing human NOD1 and deficient for the murine NOD1, we showed enhanced clearance of a lipl21- mutant compared to the complemented strain, or to what was observed in NOD1KO mice, suggesting that LipL21 facilitates escape from immune surveillance in humans. These novel mechanisms allowing L. interrogans to escape recognition by the NOD receptors may be important in circumventing innate host responses.

Indexed as

Immune EvasionAnimalsAntigens, BacterialBacterial Outer Membrane ProteinsFemaleHumansImmunity, InnateLeptospiraLeptospira interrogansLeptospirosisLipoproteinsMaleMass SpectrometryMiceMice, Inbred C57BLMice, KnockoutAntigens, BacterialBacterial Outer Membrane ProteinsLipL21 protein, Leptospira interrogansLipoproteinsNOD1 protein, humanNod1 protein, mouseNod1 Signaling Adaptor ProteinNOD2 protein, humanNod2 protein, mouseNod2 Signaling Adaptor ProteinPeptidoglycan

Identifiers

PMID29211798
PMCPMC5764436
OpenAlexW2771627397

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.